化学疗法诱导的外围神经病变中的微RNA:机制和疗法
Sepide Javankiani1, Faeze Dehghani2, Foroozan Yarahmadi1
1School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Cell cycle (Georgetown, Tex.)
|December 9, 2025
概括
化疗诱导的周围神经病变 (CIPN) 涉及由microRNAs (miRNAs) 调节的复杂机制. 准特定的miRNA为早期CIPN检测和新的治疗策略提供了潜力.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 化疗诱导的周围神经病变 (CIPN) 是癌症治疗的衰弱副作用.
- CIPN表现为疼痛和麻木等感官症状,影响患者的生活质量.
- 导致CIPN的确切机制,包括神经炎症和离子通道功能障碍,尚未完全理解.
研究的目的:
- 审查微RNAs (miRNAs) 在CIPN.的发展中的作用.
- 为了探索特定的miRNAs (例如,miR-30b-5p,miR-155,miR-124,miR-21),涉及到CIPN的病原体.
- 讨论miRNAs作为CIPN.生物标记物和治疗点的潜力.
主要方法:
- 关于研究miRNA参与CIPN的综合文献综述.
- 对神经元刺激性,离子通道和质细胞激活的miRNA介导调节研究的分析.
- 检查证据支持miRNA在神经炎症和疼痛途径中的作用,与CIPN相关.
主要成果:
- 特定的miRNAs显著调节促进CIPN发展和疼痛的关键通路.
- 这些miRNAs影响离子通道功能,质细胞活动和外围神经的炎症反应.
- 有证据表明,某些miRNAs在CIPN中失调,表明它们的参与.
结论:
- 微RNA是CIPN病变的关键调节者,影响多个细胞和分子过程.
- 调查miRNA路径为CIPN机制和潜在干预提供了洞察力.
- 作为早期诊断生物标志物和在癌症患者中减轻CIPN的新疗法标,MiRNAs显示出有前途.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
524
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
524
Drugs that Stabilize Microtubules
2.6K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K
Drugs that Destabilize Microtubules
3.6K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.6K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
576
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
576
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
790
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
790
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
653
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
653


